AmirAli Talasaz, Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 236,888 shares at $50.07 ($11.9M) on 2025-06-06, disclosed to the SEC on 2025-06-09.
Scheduled sale ($11.9M) by Co-Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 1,680 | $84K | 0.7% |
| 2 | $50.07 | 39,751 | $2.0M | 16.8% |
| 3 | $50.07 | 39,751 | $2.0M | 16.8% |
| 4 | $50.09 | 77,853 | $3.9M | 32.9% |
| 5 | $50.09 | 77,853 | $3.9M | 32.9% |
| Total | $50.08 avg | 236,888 |
| $11.9M |
| 100% |
| Filing → |
| GH | SELL | 2026-05-22 | $23.1M | — | Filing → |
| GH | SELL | 2026-05-13 | $5.0M | — | Filing → |
| GH | SELL | 2025-12-10 | $8.5M | — | Filing → |